Drugs / [177Lu]Lu-OncoFAP-23
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06640413 | Oct 2025 → May 2028 expected | — | Philogen S.p.A. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [177Lu]Lu-OncoFAP-23 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06640413 ↗ |
| Modality | Other / unclassified | “radioligand therapy” NCT06640413 ↗ |